| RS2480770209 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480770240 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IB |
| RS2480770248 |
SLC26A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Achondrogenesis, type IB |
| RS2480770468 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IB |
| RS2480770517 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480770639 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480770713 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IB |
| RS2480770768 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480770954 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480771378 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480771535 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IB |
| RS2480771602 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IB |
| RS2480771712 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480774094 |
SLC26A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Achondrogenesis, type IB |
| RS2480774287 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IB |
| RS2480774313 |
SLC26A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Achondrogenesis, type IB |
| RS2480774362 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480774496 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IB |
| RS2480774684 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480775090 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IB |
| RS2480775447 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IB |
| RS2480775493 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IB |
| RS2480775838 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IB |
| RS2480776108 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480776192 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480776226 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480776529 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IB |
| RS2480776557 |
SLC26A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Achondrogenesis, type IB |
| RS2480776581 |
BLOC1S5
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 11, Hermansky-Pudlak syndrome 11 |
| RS2480776768 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480776863 |
SLC26A2
|
Health Risk |
Likely pathogenic |
— |
| RS2480777083 |
SLC26A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Achondrogenesis, type IB |
| RS2480777100 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480777265 |
SLC26A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Achondrogenesis, type IB |
| RS2480777667 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480777920 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IB |
| RS2480777937 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IB |
| RS2480778001 |
SLC26A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Achondrogenesis, type IB |
| RS2480778034 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480778039 |
SLC26A2
|
Health Risk |
Pathogenic |
Multiple epiphyseal dysplasia type 4, Atelosteogenesis type II |
| RS2480778050 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480778118 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS2480779370 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480779488 |
NSD1
|
Health Risk |
Likely pathogenic |
— |
| RS2480784692 |
H4C5
|
Health Risk |
Pathogenic |
Tessadori-Van Haaften neurodevelopmental syndrome 3, Tessadori-Van Haaften neurodevelopmental syndrome 3 |
| RS2480784697 |
H4C5
|
Health Risk |
Pathogenic |
Tessadori-Van Haaften neurodevelopmental syndrome 3, Tessadori-Van Haaften neurodevelopmental syndrome 3 |
| RS2480784824 |
H4C5
|
Health Risk |
Pathogenic |
Tessadori-Van Haaften neurodevelopmental syndrome 3, Tessadori-Van Haaften neurodevelopmental syndrome 3 |
| RS2480785279 |
H4C5
|
Health Risk |
Likely pathogenic |
H4C5-related disorder, H4C5-related disorder |
| RS2480785483 |
H4C5
|
Health Risk |
Pathogenic/Likely pathogenic |
Tessadori-Van Haaften neurodevelopmental syndrome 3, Tessadori-Van Haaften neurodevelopmental syndrome 3 |
| RS2480787718 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480788504 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480793393 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480800376 |
NR2F1
|
Health Risk |
Pathogenic |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Bosch-Boonstra-Schaaf optic atrophy syndrome |
| RS2480801085 |
NR2F1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2480801540 |
NR2F1
|
Health Risk |
Pathogenic |
— |
| RS2480802060 |
NR2F1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Epilepsy |
| RS2480802143 |
NR2F1
|
Health Risk |
Pathogenic |
— |
| RS2480802156 |
NR2F1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Bosch-Boonstra-Schaaf optic atrophy syndrome |
| RS2480802195 |
NR2F1
|
Health Risk |
Pathogenic |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Bosch-Boonstra-Schaaf optic atrophy syndrome |
| RS2480802211 |
NR2F1
|
Health Risk |
Likely pathogenic |
— |
| RS2480802260 |
NR2F1
|
Health Risk |
Likely pathogenic |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Bosch-Boonstra-Schaaf optic atrophy syndrome |
| RS2480802272 |
NR2F1
|
Health Risk |
Pathogenic |
— |
| RS2480802300 |
NR2F1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Bosch-Boonstra-Schaaf optic atrophy syndrome |
| RS2480802411 |
NR2F1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2480802503 |
NR2F1
|
Health Risk |
Pathogenic |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Bosch-Boonstra-Schaaf optic atrophy syndrome |
| RS2480802519 |
NR2F1
|
Health Risk |
Pathogenic |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Bosch-Boonstra-Schaaf optic atrophy syndrome |
| RS2480808562 |
NR2F1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2480808763 |
NR2F1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2480809148 |
NR2F1
|
Health Risk |
Pathogenic |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Bosch-Boonstra-Schaaf optic atrophy syndrome |
| RS2480809312 |
NR2F1
|
Health Risk |
Pathogenic |
— |
| RS2480810792 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480810920 |
NSD1
|
Health Risk |
Likely pathogenic |
NSD1-related disorder, NSD1-related disorder |
| RS2480811005 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480811054 |
IRF4
|
Health Risk |
Pathogenic |
Immunodeficiency 131, Immunodeficiency 131 |
| RS2480817819 |
NR2F1
|
Health Risk |
Pathogenic |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Bosch-Boonstra-Schaaf optic atrophy syndrome |
| RS2480817831 |
NR2F1
|
Health Risk |
Pathogenic |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Bosch-Boonstra-Schaaf optic atrophy syndrome |
| RS2480817945 |
NR2F1
|
Health Risk |
Likely pathogenic |
— |
| RS2480817986 |
NR2F1
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2480818013 |
NR2F1
|
Health Risk |
Likely pathogenic |
Bosch-Boonstra-Schaaf optic atrophy syndrome, Bosch-Boonstra-Schaaf optic atrophy syndrome |
| RS2480826321 |
IRF4
|
Health Risk |
Pathogenic |
Immunodeficiency 131, Immunodeficiency 131 |
| RS2480828401 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS2480829068 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480829436 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS2480830681 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS2480835055 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480837454 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480837542 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS2480842251 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS2480842959 |
FLT4
|
Health Risk |
Pathogenic |
Hereditary lymphedema type I, Hereditary lymphedema type I |
| RS2480849698 |
H4C9
|
Health Risk |
Pathogenic |
Tessadori-Van Haaften neurodevelopmental syndrome 4, Tessadori-Van Haaften neurodevelopmental syndrome 4 |
| RS2480849793 |
FLT4
|
Health Risk |
Likely pathogenic |
— |
| RS2480849970 |
H4C9
|
Health Risk |
Pathogenic |
Tessadori-Van Haaften neurodevelopmental syndrome 4, Tessadori-Van Haaften neurodevelopmental syndrome 4 |
| RS2480863500 |
VARS1
|
Health Risk |
Pathogenic |
— |
| RS2480864905 |
VARS1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with microcephaly, seizures |
| RS2480864921 |
FLT4
|
Health Risk |
Likely pathogenic |
— |
| RS2480865039 |
FLT4
|
Health Risk |
Likely pathogenic |
— |
| RS2480865554 |
FLT4
|
Health Risk |
Pathogenic |
Hereditary lymphedema type I, Hereditary lymphedema type I |
| RS2480869226 |
FLT4
|
Health Risk |
Pathogenic |
FLT4-related disorder, FLT4-related disorder |
| RS2480880177 |
FLT4
|
Health Risk |
Likely pathogenic |
Congenital heart defects, multiple types |
| RS2480883778 |
FLT4
|
Health Risk |
Pathogenic |
FLT4-related disorder, FLT4-related disorder |